Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marjan Azin, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Khattab S, Wan G, Xu S, Moseley C, Tran M, Beagles E, Lin C, Leung B, Azin M, Hao N, Reynolds KL, Demehri S, LeBoeuf NR, Semenov YR. Long-term mortality outcomes among immunotherapy recipients treated with dupilumab for the management of cutaneous immune-related adverse events. medRxiv. 2025 Jan 08. PMID: 39830283; PMCID: PMC11741467.
    Citations:
  2. Oka T, Smith SS, Son HG, Lee T, Oliver-Garcia VS, Mortaja M, Trerice KE, Isakoff LS, Conrad DN, Azin M, Raval NS, Tabacchi M, Emdad L, Das SK, Fisher PB, Cornelius LA, Demehri S. T helper 2 cell-directed immunotherapy eliminates precancerous skin lesions. J Clin Invest. 2025 Jan 02; 135(1). PMID: 39744942; PMCID: PMC11684800.
    Citations:
    Fields: MedMedicine (General)Translation:HumansAnimalsCells
  3. Son HG, Ha DT, Xia Y, Li T, Blandin J, Oka T, Azin M, Conrad DN, Zhou C, Zeng Y, Hasegawa T, Strickley JD, Messerschmidt JL, Guennoun R, Erlich TH, Shoemaker GL, Johnson LH, Palmer KE, Fisher DE, Horn TD, Neel VA, Nazarian RM, Joh JJ, Demehri S. Commensal papillomavirus immunity preserves the homeostasis of highly mutated normal skin. Cancer Cell. 2025 Jan 13; 43(1):36-48.e10. PMID: 39672169; PMCID: PMC11732714.
    Citations:
    Fields: NeoNeoplasms
  4. Oka T, Hasegawa T, Lee T, Oliver-Garcia VS, Mortaja M, Azin M, Horiba S, Smith SS, Khattab S, Trerice KE, Chen ST, Semenov YR, Demehri S. Langerhans Cells Directly Interact with Resident T Cells in the Human Epidermis. JID Innov. 2025 Jan; 5(1):100324. PMID: 39803386; PMCID: PMC11720605.
    Citations:
  5. Zhou EY, Xia Y, Oka T, Higuchi H, Hasegawa T, Park JH, Marchese E, Oliver-García VS, Azin M, Conrad DN, Smith SS, Neel VA, Demehri S. Cutaneotropic polyomavirus abundance in the nonlesional skin of keratinocyte carcinoma patients: A cross-sectional study. J Am Acad Dermatol. 2024 Nov; 91(5):974-976. PMID: 39009226; PMCID: PMC11493513.
    Citations:
    Fields: DerDermatology
  6. Park JH, Mortaja M, Son HG, Zhao X, Sloat LM, Azin M, Wang J, Collier MR, Tummala KS, Mandinova A, Bardeesy N, Semenov YR, Mino-Kenudson M, Demehri S. Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression. Nat Commun. 2024 May 30; 15(1):4099. PMID: 38816352; PMCID: PMC11139893.
    Citations: 3
    Fields: BioBiologySciScienceTranslation:HumansAnimalsCells
  7. Huang M, Xia Y, Li K, Shao F, Feng Z, Li T, Azin M, Demehri S. Carcinogen exposure enhances cancer immunogenicity by blocking the development of an immunosuppressive tumor microenvironment. J Clin Invest. 2023 10 16; 133(20). PMID: 37843274; PMCID: PMC10575722.
    Citations: 2
    Fields: MedMedicine (General)Translation:HumansAnimalsCells
  8. Azin M, Ngo KH, Hojanazarova J, Demehri S. Topical Calcipotriol Plus Imiquimod Immunotherapy for Nonkeratinocyte Skin Cancers. JID Innov. 2023 Nov; 3(6):100221. PMID: 37731472; PMCID: PMC10507651.
    Citations: 2
  9. Messerschmidt JL, Azin M, Dempsey KE, Demehri S. TSLP/dendritic cell axis promotes CD4+ T cell tolerance to the gut microbiome. JCI Insight. 2023 07 10; 8(13). PMID: 37427591; PMCID: PMC10371333.
    Citations: 4
    Fields: MedMedicine (General)Translation:AnimalsCells
  10. Azin M, Ameri AH, Nazarian RM, Cusack JC, Tsiaras WG, Asgari MM, Demehri S. Treatment of an Unresectable Cutaneous Squamous Cell Carcinoma With ED&C and 5-FU. Cutis. 2023 07; 112(1):E27-E29. PMID: 37611292.
    Citations:
    Fields: DerDermatologyTranslation:Humans
  11. Hasegawa T, Oka T, Son HG, Oliver-García VS, Azin M, Eisenhaure TM, Lieb DJ, Hacohen N, Demehri S. Cytotoxic CD4+ T cells eliminate senescent cells by targeting cytomegalovirus antigen. Cell. 2023 03 30; 186(7):1417-1431.e20. PMID: 37001502.
    Citations: 36
    Fields: CelCell BiologyTranslation:HumansCells
  12. Park JH, Mortaja M, Azin M, Nazarian RM, Demehri S. Nuclear IL-33 in Fibroblasts Promotes Skin Fibrosis. J Invest Dermatol. 2023 07; 143(7):1302-1306.e4. PMID: 36708946; PMCID: PMC10293058.
    Citations: 1
    Fields: DerDermatologyTranslation:HumansCells
  13. Vyas M, Requesens M, Nguyen TH, Peigney D, Azin M, Demehri S. Natural killer cells suppress cancer metastasis by eliminating circulating cancer cells. Front Immunol. 2022; 13:1098445. PMID: 36733396; PMCID: PMC9887278.
    Citations: 15
    Fields: AllAllergy and ImmunologyTranslation:AnimalsCells
  14. Park JH, Mortaja M, Son H, Azin M, Wang J, Collier M, Mandinova A, Semenov Y, Mino-Kenudson M, Demehri S. Statin prevents cancer development in chronic inflammation by blocking interleukin 33 expression. Res Sq. 2023 Jan 12. PMID: 36711701; PMCID: PMC9882616.
    Citations:
  15. Boieri M, Marchese E, Pham QM, Azin M, Steidl LE, Malishkevich A, Demehri S. Thymic stromal lymphopoietin-stimulated CD4+ T cells induce senescence in advanced breast cancer. Front Cell Dev Biol. 2022; 10:1002692. PMID: 36467403; PMCID: PMC9714463.
    Citations: 4
  16. Azin M, Ameri AH, Foreman RK, Neel VA, Lorenzo ME, Demehri S. Lethal Dermal Sarcoma in Immunosuppressed Patients. Oncologist. 2022 09 02; 27(9):e759-e761. PMID: 35867136; PMCID: PMC9438906.
    Citations:
    Fields: NeoNeoplasmsTranslation:Humans
  17. Choi YS, Erlich TH, von Franque M, Rachmin I, Flesher JL, Schiferle EB, Zhang Y, Pereira da Silva M, Jiang A, Dobry AS, Su M, Germana S, Lacher S, Freund O, Feder E, Cortez JL, Ryu S, Babila Propp T, Samuels YL, Zakka LR, Azin M, Burd CE, Sharpless NE, Liu XS, Meyer C, Austen WG, Bojovic B, Cetrulo CL, Mihm MC, Hoon DS, Demehri S, Hawryluk EB, Fisher DE. Topical therapy for regression and melanoma prevention of congenital giant nevi. Cell. 2022 06 09; 185(12):2071-2085.e12. PMID: 35561684; PMCID: PMC9237838.
    Citations: 7
    Fields: CelCell BiologyTranslation:HumansAnimals
  18. Guennoun R, Hojanazarova J, Trerice KE, Azin M, McGoldrick MT, Schiferle EB, Stover MP, Demehri S. Thymic Stromal Lymphopoietin Induction Suppresses Lung Cancer Development. Cancers (Basel). 2022 Apr 27; 14(9). PMID: 35565302; PMCID: PMC9104311.
    Citations: 3
  19. Azin M, Demehri S. STK11 Loss: A Novel Mechanism for Melanoma Metastasis with Therapeutic Implications. J Invest Dermatol. 2022 04; 142(4):1007-1009. PMID: 35131083.
    Citations: 2
    Fields: DerDermatologyTranslation:HumansCells
  20. Azin M, Mahon AB, Isaacman S, Seaman JE, Allen IE, Szarek M, Cornelius LA, Demehri S. Topical Calcipotriol Plus 5-Fluorouracil Immunotherapy for Actinic Keratosis Treatment. JID Innov. 2022 May; 2(3):100104. PMID: 35310879; PMCID: PMC8927816.
    Citations: 3
  21. Chang MS, Azin M, Demehri S. Cutaneous Squamous Cell Carcinoma: The Frontier of Cancer Immunoprevention. Annu Rev Pathol. 2022 01 24; 17:101-119. PMID: 35073167.
    Citations: 17
    Fields: PatPathologyTranslation:Humans
  22. Azin M, Demehri S. Innate Lymphoid Cells: New Targets for Cutaneous Squamous Cell Carcinoma Immunotherapy. J Invest Dermatol. 2021 10; 141(10):2320-2322. PMID: 34560914.
    Citations: 3
    Fields: DerDermatologyTranslation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contact@catalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resources@hms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappt@hms.harvard.edu.
Azin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.